Blind/Non-sighted
Showing 1 - 25 of >10,000
Vision Loss Partial, Hemianopia, Hemianopia Homonymous Trial in Rochester (Training in the Blind Field, Training in the Sighted
Recruiting
- Vision Loss Partial
- +4 more
- Training in the Blind Field
- Training in the Sighted Field
-
Rochester, New YorkFlaum Eye Institute, University of Rochester Medical Center
Nov 1, 2022
Stroke, Ischemic, Brain Injuries, Stroke Hemorrhagic Trial in Copenhagen (Neuro Vision Technology)
Recruiting
- Stroke, Ischemic
- +3 more
- Neuro Vision Technology
-
Copenhagen, Hellerup, DenmarkThe Institute for the Blind and Partially Sighted (IBOS)
Mar 25, 2021
Visual Impairment, Healthy Trial in Bron (Behavioral protocol, EEG protocol, fMRI protocol)
Not yet recruiting
- Visual Impairment
- Healthy
- Behavioral protocol
- +2 more
-
Bron, FranceEquipe IMPACT du CRNL, Bâtiment INSERM
Jan 19, 2022
Renal Anemia in Non-dialysis Chronic Kidney Disease Trial in Guangzhou (SAL-0951, Placebo)
Completed
- Renal Anemia in Non-dialysis Chronic Kidney Disease
- SAL-0951
- Placebo
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 23, 2023
Meniere's Disease Trial in Seoul (YPS-201b, betahistine)
Recruiting
- Meniere's Disease
- YPS-201b
- betahistine
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 17, 2023
NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- Befotertinib + Icotinib placebo
- Icotinib + Befotertinib placebo
-
Beijing, China
- +2 more
Sep 20, 2023
Non-severe Aplastic Anemia Trial (Trappa ethanolamine tablets ; ciclosporin, Placebo ; ciclosporin)
Not yet recruiting
- Non-severe Aplastic Anemia
- Trappa ethanolamine tablets ; ciclosporin
- Placebo ; ciclosporin
- (no location specified)
Mar 22, 2023
Duchenne Muscular Dystrophy Trial (Givinostat, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- Givinostat
- Placebo
- (no location specified)
Jun 27, 2023
Overweight or Obesity Trial in Shijiazhuang (TG103 22.5 mg, Placebo)
Not yet recruiting
- Overweight or Obesity
- TG103 22.5 mg
- Placebo
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 18, 2023
Healthy Volunteer Study Trial in San Antonio (CBP-4888, Placebo)
Recruiting
- Healthy Volunteer Study
- CBP-4888
- Placebo
-
San Antonio, TexasComanche Biopharma Clinical Research Site #1
Jun 1, 2023
Non-cystic Fibrosis Bronchiectasis (NCFBE) Trial in Guangzhou (HSK31858, )
Recruiting
- Non-cystic Fibrosis Bronchiectasis (NCFBE)
- HSK31858
- placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Guangzhou Medical University
Dec 6, 2022
Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )
Active, not recruiting
- Non Small Cell Lung Cancer
- CS1001 monoclonal antibody
- CS1001 placebo
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Nov 8, 2022
Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])
Not yet recruiting
- Glabellar Lines
- Botulinum Toxin Type A Injection [HG102]
- Botulinum Toxin Type A Injection [Botox]
- (no location specified)
Apr 5, 2023
Energy, Fatigue Trial in Del Mar (Recharge Placebo Control 1, Recharge Active Study Product 1, Recharge Active Study Product 2)
Not yet recruiting
- Energy
- Fatigue
- Recharge Placebo Control 1
- +3 more
-
Del Mar, CaliforniaRadicle Science, Inc
Oct 23, 2023
Infertility Trial in Hong Kong (Non-invasive Preimplantation genetic testing for aneuploidy status)
Not yet recruiting
- Infertility
- Non-invasive Preimplantation genetic testing for aneuploidy status
-
Hong Kong, Hong KongThe University of Hong Kong
Jan 5, 2023
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)
Recruiting
- Non-cystic Fibrosis Bronchiectasis
- +2 more
- AP-PA02
- Placebo
-
Farmington, Connecticut
- +1 more
Jan 13, 2023
Non-segmental Vitiligo Trial (MK-6194, Placebo)
Not yet recruiting
- Non-segmental Vitiligo
- MK-6194
- Placebo
- (no location specified)
Nov 6, 2023
Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab, Pembrolizumab biosimilar)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- Pembrolizumab
- Pembrolizumab biosimilar
- (no location specified)
Dec 19, 2022
Non-alcoholic Steatohepatitis Trial (AZD9550, Placebo)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- AZD9550
- Placebo
- (no location specified)
Apr 27, 2023
NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,
Not yet recruiting
- Non-small Cell Lung Cancer
- Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
- placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
-
Tianjing, Tianjin, ChinaTianjin cancer hospital
Nov 3, 2023
COVID-19 Trial (PanCytoVir™ (probenecid), Placebo)
Completed
- COVID-19
- PanCytoVir™ (probenecid)
- Placebo
-
Pune, IndiaPCMCs PGI Yashwantrao Chavan Memorial Hospital
Oct 11, 2022
Non-specific Low Back Pain Trial in Shanghai (Yanqing Zhitong Ointment Acupoint application, acupoint application)
Recruiting
- Non-specific Low Back Pain
- Yanqing Zhitong Ointment Acupoint application
- placebo acupoint application
-
Shanghai, ChinaLonghua Hospital
Aug 1, 2022